Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.
about
HVPG signature: A prognostic and predictive tool in hepatocellular carcinomaApplication of dual phase imaging of 11C-acetate positron emission tomography on differential diagnosis of small hepatic lesions.Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma.Comparison of artificial neural network and logistic regression models for predicting in-hospital mortality after primary liver cancer surgery.Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times.Surgical treatment for hepatocellular carcinomaImpact of multiple liver resections prior to salvage liver transplantation on survival in patients with recurrent HCCPreoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma.Hepatocellular carcinoma presenting as thoracic spinal canal metastasis with no clinical primary foci: A report of a rare case and review of the literatureSecond Hepatectomy Improves Survival in Patients With Microvascular Invasive Hepatocellular Carcinoma Meeting the Milan Criteria.Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patientsTreatment of liver cancer of middle and advanced stages using ultrasound-guided percutaneous ethanol injection combined with radiofrequency ablation: A clinical analysisUnderstanding surgical decision making in early hepatocellular carcinoma.Ulinastatin reduces cancer recurrence after resection of hepatic metastases from colon cancer by inhibiting MMP-9 activation via the antifibrinolytic pathway.Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma.A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors.LIN28 expression and prognostic value in hepatocellular carcinoma patients who meet the Milan criteria and undergo hepatectomy.Resection of a transplantable single-nodule hepatocellular carcinoma in Child-Pugh class A cirrhosis: factors affecting survival and recurrence.Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis.Treatment of hepatocellular carcinoma: a systematic review.Treatment strategy to improve long-term survival for hepatocellular carcinoma smaller than 5 cm: major hepatectomy vs minor hepatectomy.Hepatocellular carcinoma: systemic therapies and future perspectives.Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalitiesCarboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma.A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma.Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation.Long-term outcome after liver resection and clinicopathological features in patients with small hepatocellular carcinoma.Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection.Patients with multiple hepatocellular carcinomas within the UCSF criteria have outcomes after curative resection similar to patients within the BCLC early-stage criteria.Performance status enhances the selection of treatment for patients with hepatocellular carcinoma within the milan criteria.Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression.Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria.Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma.Cirrhosis and microvascular invasion predict outcomes in hepatocellular carcinoma.Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoprotein.Survival Advantage of Radiofrequency Ablation Over Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma and Good Performance Status Within the Milan Criteria
P2860
Q26738597-B14B160F-A0E9-485F-BDA8-A1994F542D43Q33590285-BC6A9BB4-821B-4745-9FF0-B06D4B2813C6Q34197835-9DCB49E6-BC4D-4BE5-A922-DA96E2218B16Q34259742-F58B7069-CF7E-473F-826A-823BAD65B2A3Q35064605-0106BDC3-E8A0-4DC9-8F72-3B8240AC46CAQ35166162-AB49CB91-2C32-4806-B9C3-3AB2678F41D3Q36053734-1486431E-700B-4D1B-9035-E10AFAA921EBQ36082204-43EDC20F-C2B1-4A84-BBD4-6D32B0B21141Q36085978-4377B159-6DCC-437D-8B0C-55FC9ABF0C5EQ36359054-90D1CA21-FBC3-4444-9C58-25725C51DBC7Q36429818-AE53025E-EB96-402E-AF57-25A50C422AD6Q36640192-AC3471A8-4162-4157-961D-0216C3A01BA0Q36806943-D1DD383D-2D8A-4F7B-B42C-51C96EE42C0CQ36848227-BAB2DBF4-AC86-4F3D-8AB6-9C5F4F5CA68AQ37002698-1727C217-91DE-46E3-A1F0-52BB6973BBA2Q37031700-E069570B-2A79-4512-A5BA-105C9FC11B44Q37183805-8FDC03E4-5135-48C6-AD03-057353FD0BEBQ37848247-F263B99A-4F9A-4C04-8FE2-BFC50E130BFEQ38033646-9AE47F5F-6628-43D3-98D5-4286263D807BQ38155508-8C53315F-0E4D-404D-A9FC-E403E6519C89Q38212000-593D320B-5567-4F56-936F-F849CB706BF6Q38246965-47799FF1-D969-4034-80A0-0A97EBF720FAQ38935703-4535D19E-2539-4CE6-B299-DE16F2C7F383Q40068989-80D79343-1CB3-4BC7-B9CC-86ED2DA57339Q40224948-70E03AAC-87D5-48D9-952C-C2199EAFA147Q40450035-B2A0CDF1-61DF-4CA7-A904-BE366AF23E9AQ40890148-3BB9549B-C701-4BDB-BC36-EEDCA6476B40Q42164576-B3932E9E-2E99-41C4-BBA8-4880EFFCE1ADQ42214107-73941D77-1063-4F5C-93B3-1E070331475EQ43408290-9267CC85-2A8C-43DC-A917-2037D9F666FDQ44018880-2109D256-5C7D-42E2-BE2C-D006E69E18AEQ46617197-F77C4B12-F9C6-428D-BE1D-75E64D5B4D14Q46952530-0779E2FB-2256-4889-8ED6-42F8F5E7A3F8Q47196961-59C33422-ED37-42BC-8814-BE4AA4410461Q50914675-0FD723E0-F707-4C8C-932D-8BE6484D46BFQ51550710-6657ABF9-9D71-4073-87E0-1C4C2902AACBQ58576422-C9E7873D-B14D-44BA-BA6C-1CB060B129ED
P2860
Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Management of small hepatocell ...... tion, resection, and ablation.
@ast
Management of small hepatocell ...... tion, resection, and ablation.
@en
type
label
Management of small hepatocell ...... tion, resection, and ablation.
@ast
Management of small hepatocell ...... tion, resection, and ablation.
@en
prefLabel
Management of small hepatocell ...... tion, resection, and ablation.
@ast
Management of small hepatocell ...... tion, resection, and ablation.
@en
P2860
P1476
Management of small hepatocell ...... tion, resection, and ablation.
@en
P2093
William R Jarnagin
P2860
P2888
P304
P356
10.1245/S10434-010-0978-3
P577
2010-04-20T00:00:00Z
P6179
1023051829